Blood test could warn cancer patients of dangerous treatment side effects
NCT ID NCT07249060
Summary
This study aims to find a way to predict which cancer patients might experience serious side effects from immunotherapy drugs. Researchers will follow 300 cancer patients starting immunotherapy and 40 people with autoimmune diseases, taking regular blood samples. They will look for patterns in blood proteins called interferons, hoping to develop a simple test to identify patients at higher risk for side effects before they occur.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMORS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hospital Universitario de Navarra
RECRUITINGPamplona, Navarre, 31008, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.